SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $619 | +15.1% | 30,071 | +113.0% | 0.01% | -25.0% |
| Q4 2022 | $538 | -100.0% | 14,116 | -79.6% | 0.01% | -77.1% |
| Q3 2022 | $2,711,000 | -41.3% | 69,233 | -51.6% | 0.04% | -38.6% |
| Q2 2022 | $4,617,000 | -18.4% | 142,955 | -16.4% | 0.06% | -20.8% |
| Q1 2022 | $5,657,000 | +144.9% | 170,910 | +227.8% | 0.07% | +132.3% |
| Q3 2021 | $2,310,000 | +33.0% | 52,134 | +70.5% | 0.03% | +63.2% |
| Q2 2021 | $1,737,000 | +460.3% | 30,580 | +637.4% | 0.02% | +280.0% |
| Q1 2021 | $310,000 | +49.8% | 4,147 | +73.2% | 0.01% | +150.0% |
| Q4 2020 | $207,000 | -85.5% | 2,395 | -89.7% | 0.00% | -92.9% |
| Q3 2020 | $1,425,000 | -9.3% | 23,310 | -38.3% | 0.03% | -31.7% |
| Q2 2020 | $1,571,000 | +152.2% | 37,786 | +1010.7% | 0.04% | +64.0% |
| Q2 2019 | $623,000 | – | 3,402 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |